{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:27:21Z","timestamp":1759541241279},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T00:00:00Z","timestamp":1478736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.aprim.2017.04.006","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T08:31:13Z","timestamp":1504254673000},"page":"340-349","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Adecuaci\u00f3n del tratamiento antitromb\u00f3tico en los pacientes con fibrilaci\u00f3n auricular no valvular. Registro AFINVA"],"prefix":"10.1016","volume":"50","author":[{"given":"Daniela","family":"Dubois Marques","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Mora Llabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juli\u00e1n","family":"Pacheco Arroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvador","family":"Gasull Insertis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Vicente Ca\u00f1izares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ildefonso","family":"Rold\u00e1n Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2017.04.006_bib0185","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: The Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke."},{"key":"10.1016\/j.aprim.2017.04.006_bib0190","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTioagulation and Risk Factors in Atrial Fibrillation (ATRIA) study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.aprim.2017.04.006_bib0195","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.aprim.2017.04.006_bib0200","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS Guideline for the Management of Patients with Atrial Fibrillation. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.aprim.2017.04.006_bib0205","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7326\/0003-4819-151-5-200909010-00003","article-title":"The net clinical benefit of warfarin anticoagulation in atrial fibrillation","volume":"151","author":"Singer","year":"2009","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.aprim.2017.04.006_bib0210","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition)","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.aprim.2017.04.006_bib0215","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2017.04.006_bib0220","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2017.04.006_bib0225","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2017.04.006_bib0230","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2017.04.006_bib0235","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor based approach: The Euro Heart Survey on Atrial Fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.aprim.2017.04.006_bib0240","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.aprim.2017.04.006_bib0245","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/hrt.2007.134486","article-title":"Short and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation","volume":"94","author":"Lopes","year":"2008","journal-title":"Heart."},{"key":"10.1016\/j.aprim.2017.04.006_bib0250","first-page":"26","article-title":"Prevalencia de fibrilaci\u00f3n auricular y caracter\u00edsticas de la fibrilaci\u00f3n auricular no valvular en la poblaci\u00f3n general. Registro AFINVA","volume":"24","author":"Mora","year":"2017","journal-title":"Rev Colomb Cardiol"},{"key":"10.1016\/j.aprim.2017.04.006_bib0255","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.aprim.2017.04.006_bib0260","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.aprim.2017.04.006_bib0265","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.amjmed.2015.07.013","article-title":"Antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation: The GLORIA-AF registry, Phase II","volume":"128","author":"Huisman","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.aprim.2017.04.006_bib0270","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eut373","article-title":"A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: Baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry","volume":"16","author":"Lip","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.aprim.2017.04.006_bib0275","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/europace\/eut263","article-title":"Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: Primary results of the PREvention oF thromboemolic events\u2014European Registry in Atrial Fibrillation (PREFER in AF)","volume":"16","author":"Kirchhof","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.aprim.2017.04.006_bib0280","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00392-011-0320-5","article-title":"Management of atrial fibrillation by primary care physicians in Germany: Baseline results of the ATRIUM registry","volume":"100","author":"Meinertz","year":"2011","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.aprim.2017.04.006_bib0285","doi-asserted-by":"crossref","first-page":"e63479","DOI":"10.1371\/journal.pone.0063479","article-title":"GARFIELD Registry Investigators. Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: Perspectives from the international, observational, prospective GARFIELD registry","volume":"8","author":"Kakkar","year":"2013","journal-title":"PLoS One."},{"key":"10.1016\/j.aprim.2017.04.006_bib0290","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1016\/j.jacc.2016.03.581","article-title":"Aspirin instead of oral anticoagulant prescription in atrial fibrillation patients at risk for stroke","volume":"67","author":"Hsu","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.aprim.2017.04.006_bib0295","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.recesp.2013.07.010","article-title":"Uso del tratamiento antitromb\u00f3tico seg\u00fan la escala CHA2DS2VASc en los pacientes con fibrilaci\u00f3n auricular en atenci\u00f3n primaria","volume":"67","author":"Barrios","year":"2014","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.aprim.2017.04.006_bib0300","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.medcli.2012.12.023","article-title":"Investigadores del estudio FIATE (Situaci\u00f3n actual de la FIbrilaci\u00f3n auricular en ATenci\u00f3n primaria en Espa\u00f1a). Caracter\u00edsticas de los pacientes y abordaje terap\u00e9utico de la fibrilaci\u00f3n auricular en atenci\u00f3n primaria en Espa\u00f1a: Estudio FIATE","volume":"141","author":"Lobos-Bejarano","year":"2013","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.aprim.2017.04.006_bib0305","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.recesp.2014.04.020","article-title":"Evaluaci\u00f3n del grado de anticoagulaci\u00f3n de pacientes con fibrilaci\u00f3n auricular en el \u00e1mbito de atenci\u00f3n primaria de Galicia. Estudio ANFAGAL","volume":"68","author":"Cinza-Sanjurjo","year":"2015","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.aprim.2017.04.006_bib0310","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.recesp.2014.11.022","article-title":"Calidad de la anticoagulaci\u00f3n con antagonistas de la vitaminaK en Espa\u00f1a: prevalencia de mal control y factores asociados","volume":"68","author":"Anguita-Sanchez","year":"2015","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.aprim.2017.04.006_bib0315","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11239-006-9022-7","article-title":"Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: The International Study of Anticoagulation Management (ISAM)","volume":"23","author":"Ansell","year":"2007","journal-title":"J Thromb Trombolysis"},{"key":"10.1016\/j.aprim.2017.04.006_bib0320","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1093\/eurheartj\/ehr134","article-title":"Anticoagulation control in Sweden: Reports of time in therapeutic range, major bleeding, and tromboembolic complications from the national quality registry AuriculA","volume":"32","author":"Wieloch","year":"2011","journal-title":"Eur Heart J."},{"key":"10.1016\/j.aprim.2017.04.006_bib0325","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.clinthera.2015.09.008","article-title":"Trends in prescribing oral anticoagulants in Canada, 2008-2014","volume":"37","author":"Weitz","year":"2015","journal-title":"Clin Ther."},{"key":"10.1016\/j.aprim.2017.04.006_bib0330","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarina in patients with atrial fibrillation: A meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2017.04.006_bib0335","first-page":"3155","volume":"45","author":"Lip","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.aprim.2017.04.006_bib0340","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/CIRCULATIONAHA.113.002927","article-title":"Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: Insights from the ORBIT-AF Registry","volume":"128","author":"Steinberg","year":"2013","journal-title":"Circulation."},{"key":"10.1016\/j.aprim.2017.04.006_bib0345","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archinternmed.2010.271","article-title":"Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation","volume":"170","author":"Hansen","year":"2010","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.aprim.2017.04.006_bib0350","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1378\/chest.07-2627","article-title":"Outcomes associated with combined antiplatelet and anticoagulant therapy","volume":"133","author":"Johnson","year":"2008","journal-title":"Chest."},{"key":"10.1016\/j.aprim.2017.04.006_bib0355","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet."},{"key":"10.1016\/j.aprim.2017.04.006_bib0360","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1161\/CIRCULATIONAHA.107.187930","volume":"116","author":"Fraker","year":"2007","journal-title":"Circulation."}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656716304991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656716304991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T04:57:05Z","timestamp":1545022625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656716304991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0212656716304991"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2017.04.006","relation":{},"ISSN":["0212-6567"],"issn-type":[{"value":"0212-6567","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adecuaci\u00f3n del tratamiento antitromb\u00f3tico en los pacientes con fibrilaci\u00f3n auricular no valvular. Registro AFINVA","name":"articletitle","label":"Article Title"},{"value":"Atenci\u00f3n Primaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aprim.2017.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}